Frandol



Combined with:

Indications and Reactions:

Role Indications Reactions
Secondary
Angina Pectoris 27.0%
Arrhythmia 9.5%
Product Used For Unknown Indication 9.5%
Hypertension 6.3%
Myocardial Infarction 6.3%
Anticoagulant Therapy 3.2%
Anxiety Disorder 3.2%
Bronchopulmonary Aspergillosis 3.2%
Cerebral Infarction 3.2%
Constipation 3.2%
Cough 3.2%
Dementia Alzheimer's Type 3.2%
Dyslipidaemia 3.2%
Epilepsy 3.2%
Hyperlipidaemia 3.2%
Hyperphosphataemia 3.2%
Arthritis 1.6%
Delirium 1.6%
Diabetes Mellitus 1.6%
Gastritis 1.6%
Hepatic Function Abnormal 11.1%
Hypoglycaemia 11.1%
Liver Disorder 11.1%
Supraventricular Tachycardia 11.1%
Ammonia Increased 5.6%
Cardiac Operation 5.6%
Face Oedema 5.6%
Gastric Ulcer Haemorrhage 5.6%
Immune Thrombocytopenic Purpura 5.6%
Large Intestine Polyp 5.6%
Platelet Count Decreased 5.6%
Pyrexia 5.6%
Sepsis 5.6%
Systemic Inflammatory Response Syndrome 5.6%
Concomitant
Hypertension 20.8%
Angina Pectoris 11.6%
Drug Use For Unknown Indication 10.1%
Prophylaxis 9.5%
Product Used For Unknown Indication 5.0%
Myocardial Infarction 4.8%
Diabetes Mellitus 4.6%
Constipation 4.3%
Angina Unstable 3.8%
Cardiac Failure 3.3%
Insomnia 3.2%
Gastritis 2.9%
Atrial Fibrillation 2.7%
Cardiac Failure Chronic 2.2%
Reflux Oesophagitis 2.2%
Hyperlipidaemia 2.1%
Rheumatoid Arthritis 2.0%
Multiple Myeloma 1.8%
Gastric Ulcer 1.7%
Pain 1.5%
Pneumonia 13.5%
White Blood Cell Count Decreased 11.0%
Cardiac Failure 7.6%
Renal Impairment 7.2%
Rhabdomyolysis 6.3%
Hypoglycaemia 5.5%
Renal Failure Acute 4.6%
Vomiting 4.6%
Interstitial Lung Disease 4.2%
Platelet Count Decreased 3.8%
Death 3.4%
Loss Of Consciousness 3.4%
Pyrexia 3.4%
Vascular Graft 3.4%
White Blood Cell Count Increased 3.4%
Cerebral Haemorrhage 3.0%
Respiratory Failure 3.0%
Sepsis 3.0%
Small Intestinal Haemorrhage 3.0%
Thrombocytopenia 3.0%